Additional recall developments have occurred involving fentanyl pain patches. On February 18, Actavis, Inc. announced a recall of 14 lots of its patches, due to a fold-over defect that may cause leaks that expose patients directly to the fentanyl gel. Previously, a Johnson & Johnson subsidiary recalled certain lots of its fentanyl patches, marketed under the name of Duragesic.
The FDA stated that damaged patches should be not be handled directly and that anyone who comes into contact with the fentanyl gel should thoroughly rinse the exposed skin with large amounts of water only, and not to use soap. Exposure to fentanyl gel can lead to life-threatening adverse events, such as respiratory depression and possible overdose.